CIRRI, MARZIA
 Distribuzione geografica
Continente #
NA - Nord America 6.655
EU - Europa 3.924
AS - Asia 2.489
SA - Sud America 569
AF - Africa 85
OC - Oceania 41
Continente sconosciuto - Info sul continente non disponibili 4
Totale 13.767
Nazione #
US - Stati Uniti d'America 6.597
RU - Federazione Russa 1.446
SG - Singapore 749
IT - Italia 705
PL - Polonia 565
CN - Cina 561
BR - Brasile 471
HK - Hong Kong 396
IE - Irlanda 323
KR - Corea 264
SE - Svezia 224
UA - Ucraina 174
DE - Germania 159
VN - Vietnam 147
IN - India 119
FI - Finlandia 104
GB - Regno Unito 71
JO - Giordania 69
FR - Francia 48
ID - Indonesia 48
AU - Australia 40
AR - Argentina 37
TR - Turchia 29
NL - Olanda 28
ES - Italia 26
CA - Canada 25
MX - Messico 18
PK - Pakistan 17
SC - Seychelles 16
BD - Bangladesh 15
CO - Colombia 15
EC - Ecuador 15
BE - Belgio 14
IQ - Iraq 14
EG - Egitto 12
DZ - Algeria 10
JP - Giappone 10
PT - Portogallo 10
ZA - Sudafrica 10
CI - Costa d'Avorio 8
MA - Marocco 8
PE - Perù 8
PY - Paraguay 8
AZ - Azerbaigian 6
KE - Kenya 6
LT - Lituania 6
NP - Nepal 6
CH - Svizzera 5
CL - Cile 5
UZ - Uzbekistan 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
KG - Kirghizistan 4
BJ - Benin 3
CZ - Repubblica Ceca 3
DM - Dominica 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
EU - Europa 3
IR - Iran 3
MY - Malesia 3
MZ - Mozambico 3
NO - Norvegia 3
OM - Oman 3
PH - Filippine 3
TN - Tunisia 3
UY - Uruguay 3
BO - Bolivia 2
CR - Costa Rica 2
DK - Danimarca 2
HN - Honduras 2
KZ - Kazakistan 2
LB - Libano 2
RO - Romania 2
SA - Arabia Saudita 2
TH - Thailandia 2
AL - Albania 1
AT - Austria 1
BB - Barbados 1
BG - Bulgaria 1
BY - Bielorussia 1
GH - Ghana 1
GR - Grecia 1
GT - Guatemala 1
HU - Ungheria 1
JM - Giamaica 1
KH - Cambogia 1
LK - Sri Lanka 1
MG - Madagascar 1
MM - Myanmar 1
MO - Macao, regione amministrativa speciale della Cina 1
NZ - Nuova Zelanda 1
PA - Panama 1
PS - Palestinian Territory 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 13.767
Città #
Santa Clara 1.527
Fairfield 665
Warsaw 560
Ashburn 524
Singapore 496
Chandler 337
Dublin 321
Hong Kong 319
Woodbridge 300
Seoul 260
Jacksonville 257
Cambridge 243
Seattle 243
Houston 230
Wilmington 196
Hefei 177
Beijing 150
Ann Arbor 135
Altamura 133
San Jose 133
Lawrence 122
Florence 118
Princeton 96
Los Angeles 93
Dallas 88
The Dalles 80
Boardman 72
Boston 68
Moscow 62
Ho Chi Minh City 59
Buffalo 58
São Paulo 50
Rome 47
Mumbai 46
San Diego 42
Melbourne 40
Medford 33
New York 32
Paris 30
Kent 29
Jakarta 28
Milan 28
Helsinki 24
Munich 23
Hanoi 22
Chicago 21
West Jordan 21
Shanghai 20
Clifton 18
Auburn Hills 17
Rio de Janeiro 15
Bengaluru 14
Falls Church 14
Brussels 13
Frankfurt Am Main 13
Modugno 13
Toronto 12
Izmir 11
Naples 11
Norwalk 11
Andover 10
Barcelona 10
Brasília 10
Council Bluffs 10
Dong Ket 10
Giza 10
Salt Lake City 10
Capaccio 9
Catania 9
Denver 9
Lappeenranta 9
London 9
Madrid 9
Verona 9
Abidjan 8
Belo Horizonte 8
Lucknow 8
Monza 8
Palermo 8
Porto Alegre 8
São Bernardo do Campo 8
Tokyo 8
Guangzhou 7
Hillsboro 7
Mexico City 7
New Delhi 7
Redondo Beach 7
Redwood City 7
Tianjin 7
Baku 6
Brooklyn 6
Curitiba 6
Da Nang 6
Genoa 6
Haiphong 6
Lisbon 6
Montreal 6
Nairobi 6
North Bergen 6
Phoenix 6
Totale 9.132
Nome #
Esercizi di ripasso 311
Solid state characterization and dissolution properties of naproxen-arginine-hydroxypropyl-B-cyclodextrin ternary systems 308
Design, characterization and in vivo evaluation of nanostructured lipid carriers (NLC) as a new drug delivery system for hydrochlorothiazide oral administration in pediatric therapy 282
Improving the therapeutic efficacy of prilocaine by PLGA microparticles: Preparation, characterization and in vivo evaluation. 270
Development of a new delivery system consisting in "drug-in cyclodextrin- in nanostructured lipid carriers" for ketoprofen topical delivery 266
Combined Approach of Cyclodextrin Complexation and Nanostructured Lipid Carriers for the Development of a Pediatric Liquid Oral Dosage Form of Hydrochlorothiazide 250
Comparative study of oxaprozin complexation with natural and chemically-modified cyclodextrins in solution and in the solid state 206
Development and Characterization of Cyclodextrin-Based Nanogels as a New Ibuprofen Cutaneous Delivery System 198
Comparative study of liposomes, transfersomes and ethosomes as carriers for improving topical delivery of celecoxib 198
CHARACTERIZATION OF THE SOLID PHASES OF PARACETAMOL AND FENAMATES AT EQUILIBRIUM IN SATURATED SOLUTIONS 194
Analysis of physicochemical properties of ternary systems of oxaprozin with randomly methylated-ß-cyclodextrin and L-arginine aimed to improve the drug solubility 186
Characterization and evaluation of different mesoporous silica kinds as carriers for the development of effective oral dosage forms of glibenclamide, 185
Comparative evaluation of polymeric and waxy microspheres for combined colon delivery of ascorbic acid and ketoprofen 182
A preliminary study for the development and optimization by experimental design of an in vitro method for prediction of drug buccal absorption 180
Combined use of bile acids and aminoacids to improve permeation properties of acyclovir 178
Comparison of liposomal and NLC (nanostructured lipid carrier) formulations for improving the transdermal delivery of oxaprozin: Effect of cyclodextrin complexation 175
Solid lipid nanoparticles as new strategy for oral delivery of nebivolol hydrochloride 172
Comparative study on triclosan interactions in solution and in the solid state with natural and chemically modified cyclodextrins 171
Characterization and dissolution properties of ketoprofen in binary and ternary solid dispersions with polyethylene glycol and surfactants 169
Characterization and microbiological evaluation of chitosan-alginate microspheres for cefixime vaginal administration 168
New solid self-microemulsifying systems to enhance dissolution rate of poorly water soluble drugs 165
Characterization of ibuproxam binary and ternary dispersions with hydrophilic carriers 162
120) Effect of cyclodextrin complexation on theophylline release from coated polymeric matrix tablets 160
Development and characterization of fast dissolving tablets of oxaprozin based on hybrid systems of the drug with cyclodextrins and nanoclays 159
Development and in vivo evaluation of an innovative “Hydrochlorothiazide-in Cyclodextrins-in Solid Lipid Nanoparticles” formulation with sustained release and enhanced oral bioavailability for potential hypertension treatment in pediatrics 158
Development of cyclodextrin hydrogels for vaginal delivery of dehydroepiandrosterone 156
Development of a cyclodextrin-based mucoadhesive-thermo-sensitive in situ gel for clonazepam intranasal delivery 154
Solid state characterization of glyburide-cyclodextrin co-ground products 152
Interaction of naproxen with ionic cyclodextrins in aqueous solution and in the solid state. 152
Tablets of “Hydrochlorothiazide in Cyclodextrin in Nanoclay”: A New Nanohybrid System with Enhanced Dissolution Properties 152
The influence of chitosan on cyclodextrin complexing and solubilizing abilities towards drugs 150
Tecnologia Farmaceutica 149
Polymeric mucoadhesive tablets for topical or systemic buccal delivery of clonazepam: Effect of cyclodextrin complexation 149
Design, Evaluation and Comparison of Nanostructured Lipid Carriers and Chitosan Nanoparticles as Carriers of Poorly Soluble Drugs to Develop Oral Liquid Formulations Suitable for Pediatric Use 148
Development and characterization of liquisolid tablets based on mesoporous clays or silicas for improving glyburide dissolution 147
Physicochemical characterization of drug-cyclodextrin complexes prepared by supercritical carbon dioxide and by conventional techniques 145
Development of liposomal and microemulsion formulations for transdermal delivery of clonazepam: Effect of randomly methylated β-cyclodextrin 143
Development of enteric-coated timed-release matrix tablets for colon targeting 140
Development and evaluation of glyburide fast dissolving tablets using solid dispersion technique 139
Determination of stability constant values of flurbiprofen-cyclodextrin complexes using different techniques 138
Photostability studies on nicardipine-cyclodextrin complexes by capillary electrophoresis. 137
Influence of cross-linking agent type and chitosan content on the performance of pectinate-chitosan beads aimed for colon-specific drug delivery 137
Study of formulation variables influencing the drug release rate from matrix tablets by experimental design 136
Influence of cyclodextrins and chitosan, separately or in combination, on glyburide solubility and permeability 135
Improvement of butamben anesthetic efficacy by the development of deformable liposomes bearing the drug as cyclodextrin complex 135
Determination of stability constant values of flurbiprofen-cyclodextrin complexes using different techniques 133
β-Sitosterol Loaded Nanostructured Lipid Carrier: Physical and Oxidative Stability, In Vitro Simulated Digestion and Hypocholesterolemic Activity 133
Niosomes Functionalized with a Synthetic Carbohydrate Binding Agent for Mannose-Targeted Doxorubicin Delivery 132
Sustained release matrix tablets of metformin hydrochloride in combination with triacetyl-ß-cyclodextrin 132
Mixture design in the optimization of a microemulsion system for EKC determination of ketorolac and related impurities 131
Development of mucoadhesive films for buccal administration of flufenamic acid: Effect of cyclodextrin complexation. 131
Cyclodextrin complexation as a fruitful strategy for improving the performance of nebivolol delivery from solid lipid nanoparticles 130
Enhancement of dehydroepiandrosterone solubility and bioavailability by ternary complexation with a-cyclodextrin and glycine 130
Fast-dissolving tablets of glyburide based on ternary solid dispersions with PEG 6000 and surfactants 130
Mixture experiment methods in the development and optimization of microemulsion formulations 130
Development of enteric-coated pectin-based matrix tablets for colonic delivery of theophylline 129
Liquid spray formulations of xibornol using self-microemulsifying drug delivery systems 129
Development of glyburide fast-dissolving tablets based on the combined use of cyclodextrins and polymers 129
Combined use of cyclodextrins and amino acids for the development of cefixime oral solutions for pediatric use 129
Influence of formulation and process variables on in vitro release of theophylline from directly-compressed Eudragit matrix tablets 126
Simultaneous effect of cyclodextrin complexation, pH, and hydrophilic polymers on naproxen solubilization 125
Evaluation and Comparison of Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs) as Vectors to Develop Hydrochlorothiazide Effective and Safe Pediatric Oral Liquid Formulations 125
Differential Scanning calorimetry as an analytical tool in the study of drug-cyclodextrin interactions 124
Optimization of glibenclamide tablet composition through the combined use of Differential Scanning Calorimetry and D-optimal mixture experimental design. 124
Role of Cyclodextrins and Drug Solid State Properties on Flufenamic Acid Dissolution Performance from Tablets 124
Physical chemical characterization of binary systems of metformin hydrochloride with triacetyl-β-cyclodextrin 123
Dissolution and permeation properties of Naproxen from solid-state systems with chitosan 122
Development and characterization of fast-dissolving tablet formulations of glyburide based on solid self-microemulsifying systems 122
Amine-and amino acid-based compounds as carbonic anhydrase activators 122
Development of fast-dissolving tablets of flurbiprofen- cyclodextrin complexes 121
Physical-chemical characterization of binary and ternary systems of ketoprofen with cyclodextrins and phospholipids 119
Differential scanning calorimetry as a screening technique in compatibility studies of DHEA extended release formulations 118
Development of enteric-coated calcium pectinate microspheres intended for colonic drug delivery 117
Improvement of oxaprozin solubility and permeability by the combined use of cyclodextrin, chitosan, and bile components 113
Development of a stable oral pediatric solution of hydrochlorothiazide by the combined use of cyclodextrins and hydrophilic polymers 112
Development of Oral Tablets of Nebivolol with Improved Dissolution Properties, Based on Its Combinations with Cyclodextrins 110
Development and evaluation of an in vitro method for prediction of human drug absorption: II. Demonstration of the method suitability 109
INVESTIGATION OF THE EFFECTS OF GRINDING AND CO-GRINDING ON PHYSISCOCHEMICAL PROPERTIES OF GLISENTIDE 108
Influence of the preparation method on the physical-chemical properties of ketoprofen-cyclodextrin-phosphatidylcholine ternary systems 107
Multiple Roles of Chitosan in Mucosal Drug Delivery: An Updated Review 107
Effects of cyclodextrins and chitosan on gliburide dissolution and permeability through intestinal epithelial cells (Caco 2) 106
Microspheres for colonic delivery of ketoprofen-hydroxypropyl-ß-cyclodextrin complex 102
Influence of solvent composition on the solid phase at equilibrium with saturated solutions of quinolones in different sovent mixtures 100
Innovative formulazioni liquide a base di propranololo a confronto con le attuali formulazioni nella terapia pediatrica 100
Proprietà biofarmaceutiche e problemi di biodisponibilità: test in vitro 97
Development of a sustained-release matrix tablet formulation of DHEA as ternary complex with alpha-cyclodextrin and glycine 96
Principi di calcolo farmaceutico 94
Development and microbiological evaluation of chitosan and chitosan-alginate microspheres for vaginal administration of metronidazole 94
Development and evaluation of an in vitro method for prediction of human drug absorption: I. Assessment of artificial membrane composition. 90
Development of a Hydroxypropyl-beta -Cyclodextrin-based liquid formulation for the oral administration of propranolol in pediatric therapy 89
Preparation of glyburide nanocrystals with improved dissolution properties by dry-ball- and wet-bead- milling: Systematic comparison by experimental design of the performance of the two methods. 87
Physicochemical characterization of DHEA-cyclodextrin-glycine ternary systems 83
Les plans d’experiences des melanges dans l’optimisation d’un systeme de microemulsion par l’analyse d’electrophorese capillaire-Mixture design in the optimization of a microemulsion system for capillary electrophoresis analysis 80
Experimental design in the study of microemulsions. Use of a new oil phase for MEEKC analysis 78
Quality by Design approach for developing Chitosan-Ca-alginate microspheres for colon delivery of Celecoxib-hydroxypropyl-beta-cyclodextrin-PVP complex. 75
Development of Oral Tablets of Nebivolol with Improved Dissolution Properties, Based on Its Combinations with Cyclodextrins 71
Ternary systems of naproxen with hydroxypropyl-ß-cyclodextrin and aminoacids 70
null 63
Pediatric Orally Disintegrating Tablets (ODTs) with Enhanced Palatability Based on Propranolol HCl Coground with Hydroxypropyl-β-Cyclodextrin 58
On-body drug delivery systems: State-of-the-art technologies, clinical application, and future perspectives 44
Totale 13.930
Categoria #
all - tutte 37.798
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.798


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021471 0 0 0 0 0 0 31 88 80 154 49 69
2021/2022627 35 56 84 12 15 30 54 37 34 15 109 146
2022/20231.574 144 321 42 132 121 262 211 68 181 23 43 26
2023/2024679 33 64 108 36 39 40 41 171 9 54 39 45
2024/20254.200 142 416 284 572 1.345 494 82 206 189 120 216 134
2025/20263.190 439 833 512 446 541 210 209 0 0 0 0 0
Totale 13.940